APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory and Antipyretic Granules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-inflammatory and Antipyretic Granules Industry Growth and Trends Forecast to 2032

Report ID 173965070127 December 2025111 pages

Choose your research edition.

Industry ResearchAnti-inflammatory and Antipyretic Granules Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory and Antipyretic Granules Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory and Antipyretic Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory and Antipyretic Granules Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory and Antipyretic Granules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-inflammatory and Antipyretic Granules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-inflammatory and Antipyretic Granules include Dong'e Ejiao Co., Ltd., Guangdong Baihe Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. and Liaoning Xingao Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-inflammatory and Antipyretic Granules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-inflammatory and Antipyretic Granules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-inflammatory and Antipyretic Granules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-inflammatory and Antipyretic Granules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-inflammatory and Antipyretic Granules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-inflammatory and Antipyretic Granules Market by Company

Dong'e Ejiao Co., Ltd.

Guangdong Baihe Pharmaceutical Co., Ltd.

Guangxi Tiantianle Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hubei Dongxin Pharmaceutical Co., Ltd.

Hubei Nordeson Pharmaceutical Co., Ltd.

Jilin Xianfeng Technology Pharmaceutical Co., Ltd.

Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.

Liaoning Xingao Pharmaceutical Co., Ltd.

Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.

Shaanxi Buchang Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shenyang Junyuan Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

Yunnan Longfa Pharmaceutical Co., Ltd.

Anti-inflammatory and Antipyretic Granules Segment by Type

Pack of 10

Pack of 16

Anti-inflammatory and Antipyretic Granules Segment by Application

Online Sales

Offline Sales

Anti-inflammatory and Antipyretic Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory and Antipyretic Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory and Antipyretic Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory and Antipyretic Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-inflammatory and Antipyretic Granules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-inflammatory and Antipyretic Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pack of 10 Table 2. Major Company of Pack of 16 Table 3. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 5. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type (2021-2026) Table 8. Global Anti-inflammatory and Antipyretic Granules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 10. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type (2027-2032) Table 13. Global Anti-inflammatory and Antipyretic Granules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 15. North America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 17. Europe Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (US$ Million) Table 24. Anti-inflammatory and Antipyretic Granules Industry Trends Table 25. Anti-inflammatory and Antipyretic Granules Industry Drivers Table 26. Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges Table 27. Anti-inflammatory and Antipyretic Granules Industry Restraints Table 28. Global Anti-inflammatory and Antipyretic Granules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Company (2021-2026) Table 30. Global Anti-inflammatory and Antipyretic Granules Sales by Company (2021-2026) & (K Units) Table 31. Global Anti-inflammatory and Antipyretic Granules Sales Share by Company (2021-2026) Table 32. Global Anti-inflammatory and Antipyretic Granules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Anti-inflammatory and Antipyretic Granules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti-inflammatory and Antipyretic Granules Major Company Production Sites and Headquarters Table 35. Global Anti-inflammatory and Antipyretic Granules Company, Product Type & Application Table 36. Global Anti-inflammatory and Antipyretic Granules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti-inflammatory and Antipyretic Granules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti-inflammatory and Antipyretic Granules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026) & (K Units) Table 41. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Region (2021-2026) Table 44. Global Anti-inflammatory and Antipyretic Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2027-2032) & (K Units) Table 46. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Region (2027-2032) Table 49. Global Anti-inflammatory and Antipyretic Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 52. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application (2021-2026) Table 55. Global Anti-inflammatory and Antipyretic Granules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 57. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application (2027-2032) Table 60. Global Anti-inflammatory and Antipyretic Granules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 62. North America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 64. Europe Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (US$ Million) Table 71. Dong'e Ejiao Co., Ltd. Company Information Table 72. Dong'e Ejiao Co., Ltd. Business Overview Table 73. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 75. Dong'e Ejiao Co., Ltd. Recent Development Table 76. Guangdong Baihe Pharmaceutical Co., Ltd. Company Information Table 77. Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview Table 78. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 80. Guangdong Baihe Pharmaceutical Co., Ltd. Recent Development Table 81. Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information Table 82. Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview Table 83. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 85. Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Development Table 86. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 87. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 88. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 90. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Development Table 91. Hubei Dongxin Pharmaceutical Co., Ltd. Company Information Table 92. Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview Table 93. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 95. Hubei Dongxin Pharmaceutical Co., Ltd. Recent Development Table 96. Hubei Nordeson Pharmaceutical Co., Ltd. Company Information Table 97. Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview Table 98. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 100. Hubei Nordeson Pharmaceutical Co., Ltd. Recent Development Table 101. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information Table 102. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview Table 103. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 105. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Development Table 106. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information Table 107. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview Table 108. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 110. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Development Table 111. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information Table 112. Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview Table 113. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 115. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Development Table 116. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information Table 117. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview Table 118. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 120. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Development Table 121. Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information Table 122. Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview Table 123. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 125. Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Development Table 126. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 127. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 128. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 130. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Development Table 131. Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information Table 132. Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview Table 133. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 135. Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Development Table 136. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 137. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 138. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 140. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development Table 141. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 142. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 143. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 145. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 146. Yunnan Baiyao Group Co., Ltd. Company Information Table 147. Yunnan Baiyao Group Co., Ltd. Business Overview Table 148. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 150. Yunnan Baiyao Group Co., Ltd. Recent Development Table 151. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information Table 152. Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview Table 153. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 155. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Development Table 156. North America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 158. North America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2026) Table 159. North America Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Anti-inflammatory and Antipyretic Granules Sales Market Share Forecast by Country (2027-2032) Table 161. North America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Anti-inflammatory and Antipyretic Granules Market Share by Country (2021-2026) Table 164. North America Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Anti-inflammatory and Antipyretic Granules Market Share Forecast by Country (2027-2032) Table 166. Europe Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 168. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2026) Table 169. Europe Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Anti-inflammatory and Antipyretic Granules Market Share by Country (2021-2026) Table 174. Europe Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Anti-inflammatory and Antipyretic Granules Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Share by Country (2021-2026) Table 184. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Share Forecast by Country (2027-2032) Table 186. Latin America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 188. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2026) Table 189. Latin America Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Anti-inflammatory and Antipyretic Granules Market Share by Country (2021-2026) Table 194. Latin America Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Anti-inflammatory and Antipyretic Granules Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Share by Country (2021-2026) Table 204. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Anti-inflammatory and Antipyretic Granules Distributors List Table 209. Anti-inflammatory and Antipyretic Granules Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Anti-inflammatory and Antipyretic Granules Image Figure 2. Global Anti-inflammatory and Antipyretic Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory and Antipyretic Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-inflammatory and Antipyretic Granules Sales (2021-2032) & (K Units) Figure 5. Pack of 10 Image Figure 6. Global Pack of 10 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pack of 16 Image Figure 8. Global Pack of 16 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Anti-inflammatory and Antipyretic Granules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anti-inflammatory and Antipyretic Granules Market Share by Type 2025 VS 2032 Figure 11. North America Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type in 2025 Figure 12. North America Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type in 2025 Figure 13. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online Sales Image Figure 24. Global Online Sales Sales YoY Growth (2021-2032) & (K Units) Figure 25. Offline Sales Image Figure 26. Global Offline Sales Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Anti-inflammatory and Antipyretic Granules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Anti-inflammatory and Antipyretic Granules Market Share by Application 2025 VS 2032 Figure 29. North America Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application in 2025 Figure 30. North America Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application in 2025 Figure 31. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application in 2025 Figure 32. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application in 2025 Figure 35. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share in Value by Application in 2025 Figure 39. North America Anti-inflammatory and Antipyretic Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Anti-inflammatory and Antipyretic Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Anti-inflammatory and Antipyretic Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Anti-inflammatory and Antipyretic Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Anti-inflammatory and Antipyretic Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Anti-inflammatory and Antipyretic Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Anti-inflammatory and Antipyretic Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Anti-inflammatory and Antipyretic Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Anti-inflammatory and Antipyretic Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Anti-inflammatory and Antipyretic Granules Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Anti-inflammatory and Antipyretic Granules Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pack of 10
  • Pack of 16
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Dong'e Ejiao Co., Ltd.
  • Guangdong Baihe Pharmaceutical Co., Ltd.
  • Guangxi Tiantianle Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hubei Dongxin Pharmaceutical Co., Ltd.
  • Hubei Nordeson Pharmaceutical Co., Ltd.
  • Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Liaoning Xingao Pharmaceutical Co., Ltd.
  • Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  • Shaanxi Buchang Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shenyang Junyuan Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Yunnan Longfa Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-inflammatory and Antipyretic Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-inflammatory and Antipyretic Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-inflammatory and Antipyretic Granules Market by Type
  6. 1.3.1 Pack of 10
  7. 1.3.2 Pack of 16
  8. 1.4 Global Anti-inflammatory and Antipyretic Granules Market Size by Type
  9. 1.4.1 Global Anti-inflammatory and Antipyretic Granules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anti-inflammatory and Antipyretic Granules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anti-inflammatory and Antipyretic Granules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anti-inflammatory and Antipyretic Granules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anti-inflammatory and Antipyretic Granules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anti-inflammatory and Antipyretic Granules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-inflammatory and Antipyretic Granules Industry Trends
  2. 2.2 Anti-inflammatory and Antipyretic Granules Industry Drivers
  3. 2.3 Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory and Antipyretic Granules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-inflammatory and Antipyretic Granules Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-inflammatory and Antipyretic Granules Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-inflammatory and Antipyretic Granules Price (2021-2026)
  4. 3.4 Global Anti-inflammatory and Antipyretic Granules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-inflammatory and Antipyretic Granules Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-inflammatory and Antipyretic Granules Company, Product Type & Application
  7. 3.7 Global Anti-inflammatory and Antipyretic Granules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-inflammatory and Antipyretic Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-inflammatory and Antipyretic Granules Tier 1, Tier 2, and Tier 3
4 Anti-inflammatory and Antipyretic Granules Regional Status and Outlook
  1. 4.1 Global Anti-inflammatory and Antipyretic Granules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-inflammatory and Antipyretic Granules Historic Market Size by Region
  3. 4.2.1 Global Anti-inflammatory and Antipyretic Granules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-inflammatory and Antipyretic Granules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-inflammatory and Antipyretic Granules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-inflammatory and Antipyretic Granules Forecasted Market Size by Region
  7. 4.3.1 Global Anti-inflammatory and Antipyretic Granules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-inflammatory and Antipyretic Granules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-inflammatory and Antipyretic Granules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-inflammatory and Antipyretic Granules by Application
  1. 5.1 Anti-inflammatory and Antipyretic Granules Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Anti-inflammatory and Antipyretic Granules Market Size by Application
  5. 5.2.1 Global Anti-inflammatory and Antipyretic Granules Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-inflammatory and Antipyretic Granules Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-inflammatory and Antipyretic Granules Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-inflammatory and Antipyretic Granules Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-inflammatory and Antipyretic Granules Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-inflammatory and Antipyretic Granules Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Dong'e Ejiao Co., Ltd.
  2. 6.1.1 Dong'e Ejiao Co., Ltd. Company Information
  3. 6.1.2 Dong'e Ejiao Co., Ltd. Business Overview
  4. 6.1.3 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  6. 6.1.5 Dong'e Ejiao Co., Ltd. Recent Developments
  7. 6.2 Guangdong Baihe Pharmaceutical Co., Ltd.
  8. 6.2.1 Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  12. 6.2.5 Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Guangxi Tiantianle Pharmaceutical Co., Ltd.
  14. 6.3.1 Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  18. 6.3.5 Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Hebei Tiancheng Pharmaceutical Co., Ltd.
  20. 6.4.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  24. 6.4.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Hubei Dongxin Pharmaceutical Co., Ltd.
  26. 6.5.1 Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  30. 6.5.5 Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Hubei Nordeson Pharmaceutical Co., Ltd.
  32. 6.6.1 Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  36. 6.6.5 Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  38. 6.7.1 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  42. 6.7.5 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  44. 6.8.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  48. 6.8.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Liaoning Xingao Pharmaceutical Co., Ltd.
  50. 6.9.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  54. 6.9.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  56. 6.10.1 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  60. 6.10.5 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Shaanxi Buchang Pharmaceutical Co., Ltd.
  62. 6.11.1 Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  66. 6.11.5 Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  68. 6.12.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  72. 6.12.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Shenyang Junyuan Pharmaceutical Co., Ltd.
  74. 6.13.1 Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  78. 6.13.5 Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Sichuan Kelun Pharmaceutical Co., Ltd.
  80. 6.14.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  84. 6.14.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sichuan Luye Pharmaceutical Co., Ltd.
  86. 6.15.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  90. 6.15.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Yunnan Baiyao Group Co., Ltd.
  92. 6.16.1 Yunnan Baiyao Group Co., Ltd. Company Information
  93. 6.16.2 Yunnan Baiyao Group Co., Ltd. Business Overview
  94. 6.16.3 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  96. 6.16.5 Yunnan Baiyao Group Co., Ltd. Recent Developments
  97. 6.17 Yunnan Longfa Pharmaceutical Co., Ltd.
  98. 6.17.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  102. 6.17.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Anti-inflammatory and Antipyretic Granules Sales by Country
  2. 7.1.1 North America Anti-inflammatory and Antipyretic Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-inflammatory and Antipyretic Granules Market Size by Country
  6. 7.2.1 North America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-inflammatory and Antipyretic Granules Sales by Country
  2. 8.1.1 Europe Anti-inflammatory and Antipyretic Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-inflammatory and Antipyretic Granules Market Size by Country
  6. 8.2.1 Europe Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Country
  2. 9.1.1 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-inflammatory and Antipyretic Granules Sales by Country
  2. 10.1.1 South America Anti-inflammatory and Antipyretic Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-inflammatory and Antipyretic Granules Market Size by Country
  6. 10.2.1 South America Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country
  2. 11.1.1 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-inflammatory and Antipyretic Granules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-inflammatory and Antipyretic Granules Value Chain Analysis
  2. 12.1.1 Anti-inflammatory and Antipyretic Granules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-inflammatory and Antipyretic Granules Production Mode & Process
  7. 12.2 Anti-inflammatory and Antipyretic Granules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-inflammatory and Antipyretic Granules Distributors
  10. 12.2.3 Anti-inflammatory and Antipyretic Granules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst